Good point - I never really thought of it in that
Post# of 72440
(Total Views: 314)
Posted On: 02/23/2018 2:40:35 PM
Good point - I never really thought of it in that light. Here is the PR I was referring to:
http://www.ipharminc.com/press-release/2017/3...ncer-agent
Final sentence in paragraph 5:
"Remaining safety studies will be completed in the second half of this year."
The PR in itself is pretty robust and informs us that things look good. So I guess you could be right.
Maybe we will hear about a Bridge Study next.
http://www.ipharminc.com/press-release/2017/3...ncer-agent
Final sentence in paragraph 5:
"Remaining safety studies will be completed in the second half of this year."
The PR in itself is pretty robust and informs us that things look good. So I guess you could be right.
Maybe we will hear about a Bridge Study next.
(0)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼